All In MedTech

Device Trial Radar · NCT07948967

Physiological Associations and Prognostic Discrimination of an EIT-Derived Flow Index During Noninvasive Ventilation

Physiological Associations and Prognostic Discrimination of an Electrical Impedance Tomography-Derived Flow Index During Noninvasive Ventilation: A Multicenter Prospective Cohort With a Nested Physiological Substudy

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Sep 30, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Ruijin HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Shanghai East Hospital; Zhoukou Central Hospital; The First Affiliated Hospital of Soochow University
First posted
Nov 19, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter prospective observational cohort study with a nested physiological substudy. It aims to enroll 220 adults with acute hypoxemic respiratory failure (AHRF) initiating mask noninvasive ventilation (NIV). The study will assess the measurement feasibility, physiological associations, and early prognostic discrimination of the electrical impedance tomography (EIT)-derived flow index (EFI) during NIV. The primary objective is to estimate how well pre-landmark T1 EFI discriminates the risk of endotracheal intubation or all-cause death through 48 hours. A nested physiological substudy (n=20) will evaluate the within-patient association between EFI and airway occlusion pressure across fixed pressure support (PS) levels (5, 10, and 15 cmH2O). Clinical management remains independent of study measurements.

Conditions

  • Acute Hypoxemic Respiratory Failure
  • Noninvasive Ventilation

Interventions

  • Noninvasive Ventilation (NIV)Other

    Standard clinical care through oronasal or full-face mask. Settings are directed by the treating team.

  • Electrical Impedance Tomography (EIT) MonitoringDevice

    Continuous EIT monitoring to derive the dimensionless flow index (EFI).

  • Brief Pressure Support Adjustment and Airway Occlusion (Substudy only)Other

    Protocol-specified PS steps (5, 10, 15 cmH2O) and device-supported airway occlusions performed in the physiological substudy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Endotracheal Intubation or All-Cause Death (2h to 48h)Time frame: After 2 hours through 48 hours.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.